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Introduction
Familial Mediterranean Fever (FMF) is a genetic disease
which is frequently seen in Middle East Region. The
most common reason of morbidity and mortality is the
end stage renal failure due to amyloidosis.
Objectives
The potential risk factors of amyloidosis are known as
ethnic origin (Jewish, Armenian, Turkish, and North
African origin), non-usage of colchicines, and family his-
tory. Various investigators suggest that M694V muta-
tion, especially homozygote pattern, is a risk factor for
amyloidosis. In literatures reported from Turkey, it is
stated that there is only a limited association. In this
study, we aimed to investigate the affects of MEFV
mutations and other potential risk factors on
amyloidosis.
Methods
The findings of 396 FMF patients of our clinic was ret-
rospectively evaluated such as amyloidosis, MEFV muta-
tions, gender, clinical features, family history, ages at
initial symptoms, ages at diagnosis, the duration of col-
chicin usage. Amyloidosis was diagnosed by rectal or
renal biopsies of patients with proteinuria over than 500
mg/day.
Results
Renal amyloidosis was diagnosed at 8.3% (33) patients.
There was no difference between patients with amyloi-
dosis and without amyloidosis in terms of clinical fea-
tures, family history, ages at initial symptoms, ages at
diagnosis, the duration of colchicin usage. MEFV muta-
tion was studied in 159 of 363 patients without amyloi-
dosis and in 27 of 33 patients with amyloidosis. The
mutations detected in patients with amyloidosis were
M694V homozygote, M694V heterozygote, and com-
pound heterozygote of M694V/V726A, M694V/M680I,
V726A/M680I or V726A/R761H. The most common
mutation was M694V homozygote of patients with and
without amyloidosis (59.3% versus 32%). The frequency
of M694V homozygote of patients with amyloidosis was
statistically high from the frequency of patients without
amyloidosis (p<0.001). But there was no difference in
terms of other mutations.
Conclusion
It is shown that, the only most common risk factor of
Turkish patients is the M694V homozygote gene muta-
tion in our study. But amyloidosis is not seen in all
patients with M694V homozygote mutation. Therefore,
large series are needed to evaluate the other potential
risk factors. Close monitoring could be necessary for
patients with M694V homozygote mutation.
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